CymaBay launches study into drug for liver scarring in patients with compensated cirrhosis 28-Sep-2023 By Liza Laws A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).